EFFORT Extension Study

NCT01529255 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

576

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: telbivudine (ROADMAP)
DRUG: Telbivudine (Standard of Care)

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]